Upperton Pharma Solutions

  • Trustfeed ratings Icon
  • Trustfeed ratings Icon
  • Trustfeed ratings Icon
  • Trustfeed ratings Icon
  • Trustfeed ratings Icon

Nottingham, United Kingdom

upperton.com
Biotechnology· Pharmaceutical company

Upperton Pharma Solutions Reviews | Rating 3 out of 5 stars (5 reviews)

Upperton Pharma Solutions is located in Nottingham, United Kingdom on Albert Einstein Centre, Science Park. Upperton Pharma Solutions is rated 3 out of 5 in the category biotechnology in United Kingdom. Upperton Pharma Solutions is a specialist CDMO (contract development and manufacturing organisation) providing formulation and dosage form development services to the biotechnology and pharmaceutical industries. We offer our clients a complete development service, from early feasibility studies to process optimisation, scale up and clinical trial (GMP / IMP) manufacturing. We are able to enhance the performance and delivery of our client’s products by utilising an extensive range of formulation technologies. In particular we have world leading expertise and know-how in pharmaceutical spray dryings, probably the most versatile and fastest growing technology in the industry. We have experience of working with a range of dosage forms and the expertise to develop the most challenging of molecules. Our formulation work is supported by a comprehensive range of analytical services for product testing and ICH stability studies. Upperton has an extensive, multinational client-base, ranging from virtual and small start-ups to global pharma companies. We pride ourselves on our client-focused, flexible approach and scientific excellence.

Address

Albert Einstein Centre, Science Park

Phone

+44 1158557050

Company size

11-50 employees

Headquarters

Nottingham, Nottinghamshire

Founded

1999

Accessibility

Wheelchair-accessible entrance

Open hours

...
There is no reviews yet about Upperton Pharma Solutions, be the first to write a review and give your rating to Upperton Pharma Solutions
Write review Claim Profile